Document is current
Any future updates will be listed below
-
Authors
Flannery, Alexander H.
Ortiz-Soriano, Victor
Li, Xilong
Gianella, Fabiola G.
Toto, Robert D.
Moe, Orson W.
Devarajan, Prasad
Goldstein, Stuart L.
Neyra, Javier A. http://orcid.org/0000-0002-2817-2459
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK079328-06)
National Center for Advancing Translational Sciences (UL1TR001998)
- License Information
-
More Information
Article History
Received: 3 May 2021
Accepted: 4 August 2021
First Online: 14 August 2021
Declarations
:
: The study was approved by institutional review boards at both participating sites (UTSW: STU 112014-065 and UK: 16-0936-F1V). Patients or their legally authorized representatives provided written, informed consent.
: Not applicable.
: AHF and PD have received grant funding from La Jolla Pharmaceutical company. The remaining authors have disclosed that they do not have any competing interests.
